Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Azacitidine
BRD4
Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Epigenetics
Methylation
NGS
Journal
Hematology/oncology clinics of North America
ISSN: 1558-1977
Titre abrégé: Hematol Oncol Clin North Am
Pays: United States
ID NLM: 8709473
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
entrez:
28
4
2020
pubmed:
28
4
2020
medline:
9
2
2021
Statut:
ppublish
Résumé
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic neoplasm with a dismal prognosis and no standard therapy. In the past, its cellular ontogenesis was obscure, and BPDCN had been erroneously named CD56
Identifiants
pubmed: 32336416
pii: S0889-8588(20)30013-7
doi: 10.1016/j.hoc.2020.01.002
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
511-521Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.